MTAP and glioblastoma: Although our study used standardized methods (NGS) for the detection of homozygous MTAP-loss in both cohorts, epigenetic silencing of MTAP via aberrant promoter methylation is another recognized mechanism for MTAP inactivation in melanoma and glioblastoma, which was not explored in the present study.47,48